Galmed Pharmaceuticals Ltd.
GLMD
$0.52
-$0.01-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.45M | 18.16M | 19.05M | 20.53M | 15.73M |
| Total Receivables | 451.00K | 80.00K | 549.00K | 433.00K | 447.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 267.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 125.00K | 124.00K | 124.00K | 123.00K | 122.00K |
| Total Current Assets | 16.03M | 18.63M | 19.72M | 21.08M | 16.30M |
|
|
|||||
| Total Current Assets | 16.03M | 18.63M | 19.72M | 21.08M | 16.30M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 267.00K | 267.00K | 267.00K |
| Total Assets | 16.03M | 18.63M | 21.58M | 22.94M | 18.68M |
|
|
|||||
| Total Accounts Payable | 1.72M | 2.00M | 1.67M | 1.37M | 1.31M |
| Total Accrued Expenses | -- | 840.00K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 355.00K | 2.00K | 798.00K | 1.05M | 499.00K |
| Total Other Current Liabilities | 355.00K | 2.00K | 798.00K | 1.05M | 499.00K |
| Total Current Liabilities | 2.08M | 2.85M | 2.47M | 2.42M | 1.81M |
|
|
|||||
| Total Current Liabilities | 2.08M | 2.85M | 2.47M | 2.42M | 1.81M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.08M | 2.85M | 2.47M | 2.42M | 1.81M |
|
|
|||||
| Common Stock & APIC | 227.02M | 226.86M | 225.39M | 224.99M | 218.85M |
| Retained Earnings | -212.69M | -210.78M | -205.96M | -204.07M | -201.57M |
| Treasury Stock & Other | -383.00K | -303.00K | -316.00K | -403.00K | -397.00K |
| Total Common Equity | 13.95M | 15.78M | 19.11M | 20.52M | 16.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.95M | 15.78M | 19.11M | 20.52M | 16.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.95M | 15.78M | 19.11M | 20.52M | 16.88M |
|
|
|||||